79401832 - 3DµS

Information

• Trademark
• 79401832

• Source

• Serial Number

  79401832

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 7 - Machines and machine tools
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  February 22, 2024
  a year ago

• Transaction Date

  June 03, 2025
  4 days ago

• Status Date

  May 15, 2025
  23 days ago

• Published for Opposition Date

  April 15, 2025
  a month ago

• Location Date

  March 27, 2025
  2 months ago

• Status Code

  802

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  LAM, HAI-LY

• Attorney Name

  Alex Patel

  Law Office Assigned Location Code

  N10

• Owners

  • Triastek, Inc.

Case File Statements

• DM0000: The mark consists of the stylized wording "3DµS".
• GS0071: Machines for the pharmaceutical processing industry, namely, print heads for 3D printers for drugs and vaccine preparations, print heads for pharmaceutical drug and vaccine printing machines, industrial robots for conveying of drugs and vaccine preparations, and packaging machines for drugs and vaccine preparations; machines for the pharmaceutical processing industry, namely, for producing drug and vaccine capsules and tablets and mixing machines for drugs and vaccines; 3D printers; 3D bioprinters
• GS0051: Veterinary preparations, namely, veterinary vaccines, greases for veterinary purposes, antibiotics for veterinary purposes, bacterial preparations for veterinary purposes, veterinary diagnostic reagents, antibodies for veterinary purposes, and anti-infective products for veterinary use; dietetic foods adapted for medical purposes; sugar for medical purposes; dental resin for temporary bridges, crowns and veneers; pharmaceutical preparations for the treatment of bone diseases; biological tissue cultures for medical purposes; fever blister treatment preparations; dysmenorrhea treatment preparations; pharmaceutical preparations for the central nervous system; oral analgesics; anticoagulants; tumor suppressing agents; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for inducing erections; stimulants for the central nervous system; pharmaceutical preparations for treating allergies; anti-diabetic pharmaceuticals; calcium channel blockers; medicinal preparations for the mouth to be applied in the form of tablets; pharmaceutical preparations for the prevention and treatment of cancer; niacinamide preparations for the treatment of acne; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for treating hypoglycemia; antihypertensives; chemotherapeutics; antivirals; anti-infectives; chemico-pharmaceutical preparations for the treatment of cancer, oncological diseases, cardiovascular and cerebrovascular diseases, respiratory diseases, genitourinary diseases, neurological diseases, immune system related diseases, gastrointestinal diseases, musculoskeletal diseases and endocrine metabolism-related diseases; living cells for medical use; parathyroid hormone preparations; contraceptive preparations; medicines for the treatment of cardiovascular and cerebrovascular diseases; hypnotic sedatives; pharmaceutical products for treating respiratory diseases
• PM0001: 3DµS; 3D MU S; 3D MICRO S; THREE DS
• GS0421: Scientific research for medical purposes in the field of cancerous diseases; pharmaceutical research services; testing of pharmaceuticals; research and development services in the field of medicines; development of pharmaceutical preparations and medicines; pharmaceutical research and development; pharmaceutical drug development services; pharmaceutical product evaluation; conducting early evaluations in the field of new pharmaceuticals; technical research in the field of pharmaceutical studies; quality testing of pharmaceutical product; advisory services relating to material testing

Case File Event Statements

• 8/8/2024 - 10 months ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 8/15/2024 - 9 months ago

  2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI

• 8/19/2024 - 9 months ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 9/11/2024 - 8 months ago

  5 - ASSIGNED TO EXAMINER Type: DOCK

• 8/19/2024 - 9 months ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/13/2024 - 8 months ago

  6 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/14/2024 - 8 months ago

  7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 9/16/2024 - 8 months ago

  8 - REFUSAL PROCESSED BY MPU Type: RFRR

• 10/8/2024 - 8 months ago

  10 - REFUSAL PROCESSED BY IB Type: RFNT

• 9/17/2024 - 8 months ago

  9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 12/20/2024 - 5 months ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/20/2024 - 5 months ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/20/2024 - 5 months ago

  11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/17/2025 - 4 months ago

  15 - FINAL REFUSAL E-MAILED Type: GNFR

• 1/17/2025 - 4 months ago

  14 - FINAL REFUSAL WRITTEN Type: CNFR

• 1/17/2025 - 4 months ago

  16 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 2/24/2025 - 3 months ago

  18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/24/2025 - 3 months ago

  17 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 2/24/2025 - 3 months ago

  19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/25/2025 - 3 months ago

  23 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 2/25/2025 - 3 months ago

  22 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 3/21/2025 - 2 months ago

  24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/9/2025 - a month ago

  25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 4/15/2025 - a month ago

  26 - PUBLISHED FOR OPPOSITION Type: PUBO

• 4/15/2025 - a month ago

  27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 5/15/2025 - 23 days ago

  28 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF

• 2/25/2025 - 3 months ago

  20 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 2/25/2025 - 3 months ago

  21 - EXAMINERS AMENDMENT E-MAILED Type: GNEA